Dacarbazine and the Agonistic TRAIL Receptor-2 Antibody Lexatumumab Induce Synergistic Anticancer Effects in Melanoma

per Engesæter, Birgit, Engebraaten, Olav, Flørenes, Vivi Ann, Mælandsmo, Gunhild Mari
Publicat 2012

Real-world data on cervical cancer risk stratification by cytology and HPV genotype to inform the management of HPV-positive women in routine cervical screening

per Hashim, Dana, Engesæter, Birgit, Baadstrand Skare, Gry, Castle, Philip E., Bjørge, Tone, Tropé, Ameli, Nygård, Mari
Publicat a Br J Cancer (2020)

hvTRA, a novel TRAIL receptor agonist, induces apoptosis and sustained growth retardation in melanoma

per Fleten, Karianne G, Flørenes, Vivi Ann, Prasmickaite, Lina, Hill, Oliver, Sykora, Jaromir, Mælandsmo, Gunhild M, Engesæter, Birgit
Publicat a Cell Death Discov (2016)

Aldehyde Dehydrogenase (ALDH) Activity Does Not Select for Cells with Enhanced Aggressive Properties in Malignant Melanoma

per Prasmickaite, Lina, Engesæter, Birgit Ø., Skrbo, Nirma, Hellenes, Tina, Kristian, Alexandr, Oliver, Nina K., Suo, Zhenhe, Mælandsmo, Gunhild M.
Publicat 2010

Impact of scheduled appointments on cervical screening participation in Norway: a randomised intervention

per Lönnberg, Stefan, Andreassen, Trude, Engesæter, Birgit, Lilleng, Rune, Kleven, Cecilia, Skare, Annelie, Johansson, Karin, Fredheim, Christina Stangeland, Tropé, Ameli
Publicat a BMJ Open (2016)

Psychological effect of cervical cancer screening when changing primary screening method from cytology to high‐risk human papilloma virus testing

per Andreassen, Trude, Hansen, Bo T., Engesæter, Birgit, Hashim, Dana, Støer, Nathalie C., Tropé, Ameli, Moen, Kåre, Ursin, Giske, Weiderpass, Elisabete
Publicat a Int J Cancer (2019)

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma

per Magnussen, Gry Irene, Emilsen, Elisabeth, Giller Fleten, Karianne, Engesæter, Birgit, Nähse-Kumpf, Viola, Fjær, Roar, Slipicevic, Ana, Flørenes, Vivi Ann
Publicat a BMC Cancer (2015)

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors

per Seip, Kotryna, Fleten, Karianne G., Barkovskaya, Anna, Nygaard, Vigdis, Haugen, Mads H., Engesæter, Birgit Ø., Mælandsmo, Gunhild M., Prasmickaite, Lina
Publicat a Oncotarget (2016)

Low-dose anisomycin sensitizes melanoma cells to TRAIL induced apoptosis

per Slipicevic, Ana, Øy, Geir Frode, Rosnes, Anne Katrine Ree, Stakkestad, Øystein, Emilsen, Elisabeth, Engesæter, Birgit, Mælandsmo, Gunhild M., Flørenes, Vivi Ann
Publicat 2013

Quality assurance of human papillomavirus (HPV) testing in the implementation of HPV primary screening in Norway: an inter-laboratory reproducibility study

per Engesæter, Birgit, van Diermen Hidle, Bianca, Hansen, Mona, Moltu, Pia, Staby, Kjersti Mangseth, Borchgrevink-Persen, Siri, Vintermyr, Olav K., Lönnberg, Stefan, Nygård, Mari, Janssen, Emiel A. M., Castle, Philip E., Christiansen, Irene Kraus
Publicat a BMC Infect Dis (2016)